Antibody levels in adult patients with coeliac disease during gluten-free diet: A rapid initial decrease of clinical importance

Journal of Internal Medicine

Volumn 256, Issue 6, 2004, Pages 519-524

  Midhagen, G ^a   Aberg A K ^b   Olcen P ^b   Jarnerot G ^b   Valdimarsson, T ^c   Dahlbom, I ^d   Hansson, T ^d,e   Ström, Magnus ^c  

^a KSS   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^d Thermo Fisher Scientific   (United States)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antibody response; Coeliac disease; Diet

Indexed keywords

ENDOMYSIUM ANTIBODY; GLIADIN ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DUODENUM BIOPSY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATIGUE; FEMALE; FOLLOW UP; GLUTEN FREE DIET; HUMAN; MALE; PAIN; PREDICTION; PRIORITY JOURNAL; SERUM; SYMPTOM; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; CELIAC DISEASE; DIET, PROTEIN-RESTRICTED; FEMALE; GLUTEN; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECOMBINANT PROTEINS; TIME FACTORS; TRANSGLUTAMINASES;

EID: 9644276934     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2004.01406.x     Document Type: Article

References (40)

1. Mylotte M, Egan-Mitchell B, McCarthy CF et al. Incidence of coeliac disease in the west of Ireland. Brit Med J 1973; 1: 703-5.
2. Hed J, Lieden G. Ottoson E et al. IgA antigliadin antibodies and jejunal mucosal lesions in healthy blood donors. Lancet 1986; 26: 215.
3. Catassi C, Rätsch IM, Fabiani E et al. Coeliac disease in the year of 2000: exploring the iceberg. Lancet 1994; 343: 200-3.
4. Salvesen HA, Böe J. Osteomalacia in sprue. Acta Med Scand 1953; 1466: 290-9.
5. Valdimarsson T, Löfman O, Toss G et al. Reversal of osteopenia with diet in adult coeliac disease. Gut 1996; 38: 322-7.
6. Collin P, Vilska S, Heinonen PK et al. Infertility and celiac disease. Gut 1996; 39: 382-4.
7. Kilander AF, Dotevall G, Fällström SP et al. Evaluation of gliadin antibodies for detection of coeliac disease. Scand J Gastroenterol 1983; 18: 377-83.
8. Chorzelski TP, Sulej J, Tchorzewska H et al. IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease. Ann N Y Acad Sci 1983; 420: 325-34.
9. Ferreira M, Lloyd Davies S, Butler M et al. Endomysial antibody: is it the best screening test for coeliac disease? Gut 1992; 33: 1633-7.
10. Ladinser B, Rossipal E, Pittschieler K. Endomysium antibodies in coeliac disease: an improved method. Gut 1994; 35: 776-8.
11. Volta U, Lenzi M, Lazzari R et al. Antibodies to gliadin detected by immunofluorescence and a micro-ELISA method: markers of active childhood and adult coeliac disease. Gut 1985; 26: 667-71.
12. Friis SU, Gudmand-Höyer E. Screening for coeliac disease in adults by simultaneous determination of IgA and IgG gliadin antibodies. Scand J Gastroenterol 1986; 21: 1058-62.
13. Ciclitira PJ. AGA Technical review on coeliac sprue. Gastroenterology 2001; 120: 1526-40.
14. Grodzinski E, Hed J, Liedén G et al. Presence of IgA and IgG antigliadin antibodies in healthy adults as measured by micro-Elisa. Effect of various cut-off levels on specificity and sensitivity when diagnosing coeliac disease. Int Arch Allergy Appl Immunol 1990; 92: 119-23.
15. Uibo O, Uibo R, Kleimola V et al. Serum IgA anti-gliadin antibodies in an adult population sample. High prevalence without coeliac disease. Dig Dis Sci 1993; 38: 2034-7.
16. Chorzelski TP, Beutner EH, Sulej J et al. IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease. Br J Dermatol 1984; III: 395-402.
17. Hällström O. Comparison of IgA-class reticulin and endomysium antibodies in coeliac disease and dermatitis herpetiformis. Gut 1989; 30: 1225-32.
18. Farell RJ. Celiac sprue. N Engl J Med 2002; 346: 180-8.
19. Dickey W, Hughes DF, McMillan SA. Reliance on serum endomysial antibody testing underestimates the true prevalence of coeliac disease by one fifth. Scand J Gastroenterol 2000; 35: 181-3.
20. Valdimarsson T, Franzén L, Grodzinsky E et al. Is small bowel biopsy necessary in adults with suspected coeliac disease and IgA anti-endomysium antibodies? Dig Dis Sci 1996; 41: 83-7.
21. McMillan SA, Haughton DJ, Biggart JD et al. Predictive value for coeliac disease of antibodies to gliadin, endomysium, and jejunum in patients attending for jejunal biopsy. Brit Med J 1991; 303: 1163-5.
22. Dietrich W, Ehnis T, Bauer M et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797-801.
23. Sulkanen S, Halttunen T, Laurila K et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998; 115: 1322-8.
24. Sardy M, Odenthal U, Karpati S et al. Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy. Clin Chem 1999; 45: 2142-9.
25. Clemente MG, Musu MP, Frau F et al. Antitissue transglutaminase antibodies outside celiac disease. J Pediatr Gastroenterol Nutr 2002; 34: 31-4.
26. Wong RC, Wilson RJ, Steele RH et al. A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits. J Clin Pathol 2002; 55: 488-94.
27. Hansson T, Dahlbom I, Rogberg S et al. Recombinant human tissue transglutaminase for diagnosis and follow-up of childhood coeliac disease. Pediatr Res 2002; 51: 700-5.
28. Burgin-Wolff A, Dahlbom I, Hadziselimovic CF et al. Antibodies against human tissue transglutaminase and endomysium in diagnosing and monitoring coeliac disease. Scand J Gastroenterol 2002; 37: 685-91.
29. Leon F, Camarero C, R-Pena R et al. Anti-transglutaminase IgA ELISA: clinical potential and drawbacks in celiac disease diagnosis. Scand J Gastroenterol 2001; 36: 849-53.
30. Marsh MN, Crowe PT. Morphology of the mucosal lesion in gluten sensitivity. Baillieres Clin Gastroenterol 1995; 9: 273-93.
31. Kaukinen K, Sulkanen S, Maki M et al. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease. Eur J Gastroenterol Heapatol 2002; 14: 311-5.
32. McMillan SA, Dickey W, Douglas JP et al. Transthyretin values correlate with mucosal recovery in patients with celiac disease taking a gluten free diet. J Clin Pathol 2001; 54: 783-6.
33. Dickey W, Hughes DF, McMillan SA. Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery. Am J Gastroenterol 2000; 95: 712-4.
34. Fotoulaki M, Nousia-Arvanitakis S. Augoustidou-Savvopoulou P et al. Clinical application of immunological markers as monitoring tests in celiac disease. Dig Dis Sci 1999; 44: 2133-8.
35. Sblattero D, Berti I, Trevisiol C et al. Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol 2000; 95: 1253-7.
36. Hansson T, Dahlbom I, Hall J et al. Antibody reactivity against human and guinea pig tissue transglutaminase in children with celiac disease. J Pediatr Gastroenterol Nutr 2000; 30: 379-84.
37. Fabiani E, Catassi C and the International Working Group on Eu-tTG. The serum IgA class anti-tissue transglutaminase antibodies in the diagnosis and follow up of coeliac disease. Results of an international multi-centre study. Eur J Gastroenterol Hepatol 2001; 13: 659-65.
38. Burgin-Wolff A, Berger R, Gaze H et al. IgG, IgA and IgE gliadin antibody determinations as screening test for untreated coeliac disease in children, a multicentre study. Eur J Pediatr 1989; 148: 496-502.
39. Tursi A, Brandimarte G, Giorgetti GM. Lack of usefulness in assessing histologie recovery after gluten-free diet in celiac disease. J Clin Gastroenterol 2003; 37: 387-91.
40. Vahedi K, Mascart F, Mary JY et al. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet. Compliance in adult celiac disease. Am J Gastroenterol 2003; 98: 1079-87.